EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.
Zhou Q, van den Berg NS, Rosenthal EL, Iv M, Zhang M, Vega Leonel JCM, Walters S, Nishio N, Granucci M, Raymundo R, Yi G, Vogel H, Cayrol R, Lee YJ, Lu G, Hom M, Kang W, Hayden Gephart M, Recht L, Nagpal S, Thomas R, Patel C, Grant GA, Li G.
Zhou Q, et al. Among authors: recht l.
Theranostics. 2021 May 21;11(15):7130-7143. doi: 10.7150/thno.60582. eCollection 2021.
Theranostics. 2021.
PMID: 34158840
Free PMC article.
Clinical Trial.